59 Current news of PerkinElmer

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
PerkinElmer to Acquire In-Vitro Diagnostics Company

Endocrinology testing specialist expands PerkinElmer’s immunodiagnostics segment

19-May-2021

PerkinElmer, Inc. and Immunodiagnostic Systems Holdings PLC (IDS) announced that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire IDS for approximately $155 million (£110 Million). The transaction has a total enterprise value of ...

more

image description
PerkinElmer Completes Acquisition of Oxford Immunotec

12-Mar-2021

PerkinElmer, Inc. announced that the Company has completed its previously announced acquisition of Oxford Immunotec Global PLC (Oxford Immunotec). PerkinElmer originally announced its intent to acquire Oxford Immunotec on January 7, 2021. “Oxford Immunotec’s global role in fighting tuberculosis, ...

more

image description
FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing

25-Mar-2020

PerkinElmer, Inc. announced that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the Company’s New Coronavirus RT-PCR test. Clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this kit ...

more

PerkinElmer Announces Leadership Succession Plan

23-Aug-2019

PerkinElmer, Inc. announced that after a career of more than 20 years at the Company, including the last 12 years as chief executive officer, Robert F. Friel, has decided to retire as chairman and CEO and member of the board of directors as of the end of the Company’s fiscal year on December 29, ...

more

PerkinElmer appoints President & Chief Operating Officer

12-Dec-2018

PerkinElmer announced that its board of directors has named Prahlad Singh president and chief operating officer, effective January 1, 2019. In his expanded position, Dr. Singh will have responsibility for both the Discovery and Analytical Solutions (DAS) and Diagnostics operating divisions of the ...

more

PerkinElmer appoints Chief Financial Officer

12-Apr-2018

PerkinElmer, Inc. announced the appointment of James M. Mock to senior vice president and chief financial officer (CFO), effective May 1, 2018. Andy Wilson, PerkinElmer’s current senior vice president and CFO, who previously announced his retirement from PerkinElmer, will remain with the Company ...

more

PerkinElmer to acquire EUROIMMUN for approximately $1.3 Billion

19-Jun-2017

PerkinElmer, Inc. announced that it has entered into a definitive agreement to acquireEUROIMMUN Medical Laboratory Diagnostics AG. The agreement provides that PerkinElmer will acquire up to a 100% stake in EUROIMMUN. The total purchase price of the transaction based on all outstanding shares ...

more

PerkinElmer completes sale of medical imaging business to Varex Imaging

03-May-2017

PerkinElmer announced that the company has completed the sale of its Medical Imaging business to Varex Imaging Corporation. PerkinElmer announced its intent to sell its Medical Imaging business, a supplier of flat panel X-ray detectors that serve as components for industrial, medical and dental ...

more

PerkinElmer announces third quarter results

GAAP Revenue of $548 million versus $563 million in the comparable prior period

08-Nov-2016

PerkinElmer, Inc. reported financial results for the third quarter ended October 2, 2016. The Company reported GAAP earnings per share from continuing operations of $0.52, as compared to $0.48 in the third quarter of 2015. GAAP revenue in the third quarter of 2016 was $548.1 million, as compared ...

more

PerkinElmer Elects Samuel Chapin to Board of Directors

19-Oct-2016

PerkinElmer, Inc. announced that Samuel R. Chapin has been elected to the Company's Board of Directors. "I am pleased to welcome Samuel to our Board, as he brings extensive experience in strategic advisory, mergers and acquisitions, and deal financing for a wide range of transactions, along with ...

more

Page 1 From 6
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE